557 related articles for article (PubMed ID: 14655291)
1. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
Tervaert JW; Stegeman CA
Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
Jayne D; Rasmussen N; Andrassy K; Bacon P; Tervaert JW; Dadoniené J; Ekstrand A; Gaskin G; Gregorini G; de Groot K; Gross W; Hagen EC; Mirapeix E; Pettersson E; Siegert C; Sinico A; Tesar V; Westman K; Pusey C;
N Engl J Med; 2003 Jul; 349(1):36-44. PubMed ID: 12840090
[TBL] [Abstract][Full Text] [Related]
3. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
Pagnoux C; Mahr A; Hamidou MA; Boffa JJ; Ruivard M; Ducroix JP; Kyndt X; Lifermann F; Papo T; Lambert M; Le Noach J; Khellaf M; Merrien D; Puéchal X; Vinzio S; Cohen P; Mouthon L; Cordier JF; Guillevin L;
N Engl J Med; 2008 Dec; 359(26):2790-803. PubMed ID: 19109574
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
[TBL] [Abstract][Full Text] [Related]
5. [Wegener's granulomatosis and microscopic polyangiitis].
Pagnoux C
Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109
[TBL] [Abstract][Full Text] [Related]
6. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
Slot MC; Tervaert JW; Boomsma MM; Stegeman CA
Arthritis Rheum; 2004 Apr; 51(2):269-73. PubMed ID: 15077271
[TBL] [Abstract][Full Text] [Related]
7. [ANCA-associated vasculitis].
Sinico RA; Sabadini E; Boeri R; Radice A
G Ital Nefrol; 2002; 19(2):125-36. PubMed ID: 12195410
[TBL] [Abstract][Full Text] [Related]
8. When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy?
Flossmann O; de Groot K
Nat Clin Pract Nephrol; 2007 May; 3(5):236-7. PubMed ID: 17457358
[No Abstract] [Full Text] [Related]
9. Etanercept plus standard therapy for Wegener's granulomatosis.
Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
N Engl J Med; 2005 Jan; 352(4):351-61. PubMed ID: 15673801
[TBL] [Abstract][Full Text] [Related]
10. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
11. Primary systemic vasculitis.
Day C; Savage C
Minerva Med; 2001 Oct; 92(5):349-63. PubMed ID: 11675579
[TBL] [Abstract][Full Text] [Related]
12. Relapses in patients with a systemic vasculitis.
Gordon M; Luqmani RA; Adu D; Greaves I; Richards N; Michael J; Emery P; Howie AJ; Bacon PA
Q J Med; 1993 Dec; 86(12):779-89. PubMed ID: 7906421
[TBL] [Abstract][Full Text] [Related]
13. Review article: Progress of treatment in ANCA-associated vasculitis.
Jayne D
Nephrology (Carlton); 2009 Feb; 14(1):42-8. PubMed ID: 19335843
[TBL] [Abstract][Full Text] [Related]
14. Optimizing the therapeutic strategies in ANCA-associated vasculitis--single centre experience with international randomized trials.
Vanková Z; Ríhová Z; Jancová E; Rysavá R; Merta M; Tesar V
Prague Med Rep; 2006; 107(2):199-212. PubMed ID: 17066740
[TBL] [Abstract][Full Text] [Related]
15. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.
Martinez Del Pero M; Chaudhry A; Jones RB; Sivasothy P; Jani P; Jayne D
Clin Otolaryngol; 2009 Aug; 34(4):328-35. PubMed ID: 19673980
[TBL] [Abstract][Full Text] [Related]
16. Adverse effects of therapy for ANCA-associated vasculitis.
Turnbull J; Harper L
Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):391-401. PubMed ID: 19508946
[TBL] [Abstract][Full Text] [Related]
17. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis.
Koldingsnes W; Nossent JC
J Rheumatol; 2003 Jan; 30(1):80-8. PubMed ID: 12508394
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis.
Lurati-Ruiz F; Spertini F
J Rheumatol; 2005 Nov; 32(11):2167-72. PubMed ID: 16265696
[TBL] [Abstract][Full Text] [Related]
19. Wegener's granulomatosis.
Lamprecht P; Gross WL
Herz; 2004 Feb; 29(1):47-56. PubMed ID: 14968341
[TBL] [Abstract][Full Text] [Related]
20. [ANCA(antineutrophil cytoplasmic antibodies)-associated vasculitis in a man with extreme fatigue, fever and progressive renal dysfunction].
Bakashvili N; Swaak AJ; Tervaert JW; Dees A
Ned Tijdschr Geneeskd; 2008 Apr; 152(17):1009-14. PubMed ID: 18549177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]